Patients go online to find out whether it is worth it to adhere to their treatment. This presents a complete mind-shift in pharma’s thinking about adherence – especially in light …
Name:
Email:
Great news, we've signed you up. Sorry, we weren't able to sign you up. Please check your details, and try again.
MS patient meets German clinical trial
Becoming a "patient-like-me" in EU
